- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02011672
Effect of Milk Ingredients on Glucose Regulation and Inflammation
Effect of Milk Ingredients on Glucose Regulation and Inflammation in Overweight Subjects
Background: Recent advances in science have established a fundamental role for low grade chronic inflammation in mediating all stages of most of the non-communicable diseases associated with ageing. Pro-inflammatory effects of hyperglycemia have been described. Dairy and its components are known to exert beneficial effects on postprandial hyperglycemia. This study investigates if dairy, normal and enriched, can reduce chronic inflammation via improvement in glucose regulation.
Objective: To compare the effect of a nutrient-enriched dairy drink on parameters of glucose regulation and postprandial inflammation with the effect of a standard milk drink, within a population of overweight, apparently healthy subjects.
Study design: The study is designed as a double-blind randomized placebo-controlled parallel trial during 7 weeks, during which the test and reference products will be consumed at home.
Main study parameters/endpoints: The difference in absolute change in fasting blood plasma concentration of glucose, insulin and IL-6, from baseline to endpoint, and the difference in postprandial response of plasma concentration of glucose, insulin and IL-6 at the end of the treatment period, between subjects consuming the test and reference product.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ede, Netherlands
- NIZO food research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI 28-35 kg/m2
- Waist circumference >102 cm
- Healthy as assessed by the NIZO lifestyle and health questionnaire and results of the pre-study safety laboratory tests.
- Regular and normal Dutch eating habits as assessed by the NIZO lifestyle and health questionnaire (3 main meals per day)
- Habitual consumption of dairy products as assessed by dietary questionnaire
- Voluntary participation
- Having given written informed consent
- Willing to comply with study procedures
- Access to internet
- Willing to accept use of all encoded data, including publication, and the confidential use and storage of all data for at least 15 years.
- Willing to accept disclosure of the financial benefit of participation in the study to the authorities concerned
Exclusion Criteria:
- Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study
- Participation in any non-invasive clinical trial up to 30 days before Day 01 of this study, including no blood sampling and/or oral, intravenous or inhalatory administration of substances
- Having a history of medical or surgical events that may significantly affect the study outcome, including: Inflammatory bowel disease, ulcers, gastrointestinal or rectal bleeding; major gastrointestinal tract surgery such as gastrectomy, gastroenterostomy, or bowel resection; known or suspected gastrointestinal strictures
- Medical drug use; antibiotics, laxatives, glucose lowering drugs, insulin; all medication with an inflammation inhibiting effect (e.g. NSAIDS, corticosteroids) and/or an effect on blood coagulation (e.g. coumarins, inhibitors of thrombin or factor Xa, acetylsalicylic acid, antidepressants from the group of serotonin reabsorption inhibitors, tranexamin acid)
- Mental status that is incompatible with the proper conduct of the study
- A self-reported reported food allergy or sensitivity (wheat, milk, lactose, eggs, nuts, etc)
- Alcohol consumption > 28 units/week and 4/day
- Exercise > 3 hours/week
- Smoking >20 cigarettes/day
- Reported unexplained weight loss or weight gain of > 3 kg in the month prior to pre-study screening
- Reported slimming or medically prescribed diet
- Reported vegan or macrobiotic life-style
- Recent blood donation (<1 month prior to Day 01 of the study)
- Not willing or afraid to give up blood donation during the study
- Personnel of NIZO food research or Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives
- Not having a general practitioner
- Not willing to accept information-transfer concerning participation in the study, or information regarding his health, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from his general practitioner
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: nutrient-enriched milk
consumption of 250 ml three times per day
|
|
Placebo Comparator: regular milk
consumption of 250 ml three times per day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change in fasting blood glucose
Time Frame: baseline and 7 weeks
|
baseline and 7 weeks
|
change in fasting plasma interleukin-6 (IL-6)
Time Frame: baseline and 7 weeks
|
baseline and 7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
postprandial area under the curve for plasma glucose
Time Frame: 7 weeks
|
7 weeks
|
change in fasting insulin
Time Frame: 7 weeks
|
7 weeks
|
postprandial area under the curve for plasma insulin
Time Frame: 7 weeks
|
7 weeks
|
postprandial area under the curve for plasma IL-6
Time Frame: 7 weeks
|
7 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL46103.081.13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Regulation
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
German Institute of Human NutritionTechnical University of MunichCompletedDisorder of Glucose RegulationGermany
-
Lund UniversityAnti-Diabetic Food CentreCompletedPostprandial Blood Glucose RegulationSweden
-
University of TorontoCompletedGlucose Metabolism | Appetite Regulation | HealthCanada
-
United States Department of Agriculture (USDA)CompletedSubstrate Oxidation | Glucose Regulation | Substrate AbsorptionUnited States
-
Ohio UniversityCompletedInflammation | Sleep | Glucose RegulationUnited States
-
PHJ van der VoortAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)CompletedDisorder of Glucose RegulationNetherlands
-
University of ValenciaMinisterio de Ciencia e Innovación, SpainRecruitingIntervention on Socio-emotional Development and Well-being Through ICTs in Early Adulthood (EMOWELL)Emotion RegulationSpain
Clinical Trials on nutrient-enriched milk
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
Institute of Child HealthCompletedBirth WeightUnited Kingdom
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingMicrobial Colonization | Growth Failure | Breast Milk Expression | Feeding Disorder Neonatal | Prematurity; ExtremeUnited States
-
NestléWithdrawnInfant, Small for Gestational Age
-
USDA, Western Human Nutrition Research CenterUniversity of Copenhagen; Bill and Melinda Gates Foundation; International Centre... and other collaboratorsRecruitingHuman Milk Nutrient Reference ValuesDenmark, Bangladesh, Brazil, Gambia
-
Mead Johnson NutritionUniversity of North Carolina, Chapel HillTerminatedDeclarative MemoryUnited States
-
Unity Health TorontoCompletedPost Prandial Blood GlucoseCanada
-
Institut National de Recherche pour l'Agriculture...National Research Agency, FranceCompleted
-
International Medical UniversityUniversity of Malaya; National University of MalaysiaCompletedConstipationMalaysia
-
Nantes University HospitalTerminated